Viewing nowCombinationARBT-S Tablet 80/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201605854 · Approved 2016.09.30 · Insurance code 647804450
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with either amlodipine or telmisartan monotherapy. This drug effectively lowers blood pressure, reduces the risk of cardiovascular disease, and helps maintain a healthy lifestyle through better blood pressure control.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine regimen is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). Since amlodipine clearance is reduced in patients aged 75 years or older, treatment should be initiated at a low dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so if pregnancy is confirmed, it should be discontinued immediately. This medication should not be used by women who are pregnant or breastfeeding, or by patients with severe liver or heart dysfunction, or those who are allergic to the active ingredients or similar components. Particular caution should be exercised when administering this drug to patients with mild liver dysfunction, low blood pressure, or severely impaired kidney function, and dosage should be adjusted according to the physician's instructions. Common side effects such as dizziness or edema may occur, and serious side effects may rarely occur, so any unusual symptoms must be reported to the healthcare provider immediately. This medication may interact with other drugs, therefore, it is essential to inform the doctor or pharmacist of any medications currently being taken, especially when used concurrently with specific cardiac drugs, diuretics, or potassium supplements. It is safest not to use this medication during pregnancy, and it is advisable to avoid it while breastfeeding as well. The use of this medication in children or older adults is either not recommended or requires caution, so it is important to consider age when deciding on administration and dosage. In case of overdose, blood pressure may drop sharply; therefore, seek appropriate medical treatment immediately if symptoms appear. This medication should be stored out of reach of children and should be taken directly from the container when consumed.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly closed container that blocks light. Additionally, it is recommended to store the medication at room temperature between 1 and 30 degrees Celsius.
White to light yellow and pale blue biconvex oval double-coated tablets
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.